incontinence
Conditions
Interventions
Group 1 :Er:YAG laser treatment group
Group 2:Biofeedback electrical stimulation
Sponsors
Pudong New Area Gongli Hospital, Naval Military Medical University.
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Women aged >= 18 years; 2. Mild to moderate cases clinically diagnosed as simple stress urinary incontinence (using 1-hour urine pad test graduation method); 3. Those who agree to participate in this clinical trial and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who have undergone pelvic surgery or urinary incontinence surgery; 2. Patients with urge urinary incontinence or filling urinary incontinence or true urinary incontinence or severe stress urinary incontinence; 3. Patients with asexual life history; 4. Bladder tumors or patients who have received radiation therapy; 5. Patients with uncured urinary tract infection or bladder infection; 6. Patients with vesicovaginal fistula; 7. Patients with damaged vaginal cavity, vaginal opening or vestibule; 8. Patients diagnosed with endometriosis; 9. Patients with pelvic organ prolapse grade >= grade II (according to POP-Q); 10. Patients with fecal incontinence; 11. Patients with unexplained vaginal bleeding or cervical lesions (such as erosion); 12. Severe liver and kidney dysfunction (ALT > 3 times the upper limit of normal; creatinine > 225 umol/L); 13. Those who suffer from diseases that will cause difficulties in treatment and evaluation (such as sepsis, bacteremia, toxemia, severe metabolic diseases, cancer metastasis, mental illness, etc.); 14. Patients suffering from other diseases that may cause difficulties in the trial or significantly shorten the patient's life expectancy (< 1 year), such as tumors, liver diseases, cardiac insufficiency, etc., or patients whose life expectancy is less than 12 months; 15. Pregnant and lactating women, or those who have family planning; 16. Patients with poor compliance, who are unwilling or unable to complete the treatment and follow-up plan; 17. Patients who are participating in clinical trials of other drugs or medical devices; 18. Other investigators consider patients who are not suitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effective rate;Urinary Incontinence Questionnaire; | — |
Countries
China
Contacts
Public ContactJianwei Lv
Pudong New Area Gongli Hospital, Naval Military Medical University
Outcome results
None listed